Publicaciones (78) Publicaciones de Fernando Aranda Vega

2024

  1. Animal models of disease: Achievements and challenges

    Methods in Cell Biology

  2. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

  3. Peritoneal carcinomatosis in mouse models

    Methods in Cell Biology (Academic Press Inc.), pp. 67-78

  4. Preface

    Methods in Cell Biology

  5. Tumor slice culture system for ex vivo immunotherapy studies

    Methods in Cell Biology (Academic Press Inc.)

  6. Unveiling the multifaceted antitumor effects of interleukin 33

    Frontiers in Immunology

2023

  1. Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

    Oncoimmunology, Vol. 12, Núm. 1, pp. 2147317

  2. Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis

    Journal for immunotherapy of cancer, Vol. 11, Núm. 11

  3. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616

  4. The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis

    OncoImmunology

2022

  1. CD6 deficiency impairs early immune response to bacterial sepsis

    iScience, Vol. 25, Núm. 10

  2. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution

    Prostate, Vol. 82, Núm. 14, pp. 1331-1337

  3. Novel strategies exploiting interleukin-12 in cancer immunotherapy

    Pharmacology and Therapeutics, Vol. 239

  4. Omentum: Friend or foe in ovarian cancer immunotherapy?

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 117-131

  5. Overcoming the limitations of cytokines to improve cancer therapy

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 107-141

  6. Revisiting Intracavitary Immunotherapy of Cancer

    Clinical Cancer Research, Vol. 28, Núm. 10, pp. 1993-1995

  7. Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

    OncoImmunology, Vol. 11, Núm. 1

2021

  1. Firefighters for the wrong type of inflammation in tumors

    Cancer Discovery, Vol. 11, Núm. 10, pp. 2372-2374

  2. Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11

  3. Mouse models of peritoneal carcinomatosis to develop clinical applications

    Cancers, Vol. 13, Núm. 5, pp. 1-11